Dapirolizumab pegol, a novel CD40L inhibitor, is superior to placebo for achieving low disease activity and remission in systemic lupus erythematosus, according to data presented at the EULAR 2025 ...

Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...

Candid Therapeutics, Inc. ("Candid"), a clinical-stage biotechnology company redefining the treatment of autoimmune and ...

From subtle rashes to sun-safety strategies, Drs Maureen McMahon and John Edminister discuss how to recognize cutaneous lupus and protect patients from UV-triggered flares.

A new approach induces the patient’s body to produce its own CAR-T cells, relying on the same messenger RNA (mRNA) technology ...

Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...

A Bridgeport resident says the CT DOC's failure to provide timely treatment led to 28 rounds of chemotherapy and the removal ...

First CD5 Targeted Therapy Commercial Launch Expected By 2030 Says Kuick ResearchDelhi, June 19, 2025 (GLOBE NEWSWIRE) -- ...

Sudden joint pain, or arthralgia, can stem from various causes, ranging from viral infections like the flu and COVID-19 to ...

Find the latest Sjogrens Disease news articles, videos, podcasts, and meeting coverage from medical experts and key opinion ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.